Evaluation
*
Very PoorPoorNeutralGoodExcellent
Overall Evaluation
Content
Usefulness
Quality
*
(1=Strongly Disagree, 5= Strongly Agree)
12345
Discuss AHA/ACC treatment guidelines and recommendations regarding patient screening, and treatment selection.
Analyze the therapeutic landscape of antiplatelet agents, including dual and triple antiplatelet therapy.
Develop personalized treatment plans to effectively address risk-benefit considerations to improve overall quality of life in patients with ACS.
*
*
(1=NOT at all confident, 2=Somewhat confident, 3=Confident, 4=Very confident, 5=EXTREMELY confident, N/A=Not within the scope of my practice)
12345N/A
Understanding of recent clinical trial data for patients with ACS?
Ability to develop personalized treatment plans to effectively address risk-benefit considerations to improve overall quality of life in patients with ACS?
*
*
*
(1=Never, 2=Not often, 3=Sometimes, 4=Often, 5=Always, N/A=Not applicable to me)
12345N/A
Utilize risk score tools in the clinical decision making for patients with ACS
Individually evaluate risk of bleeding complication weighed against the clinical benefit
Apply early invasive management strategies, even for high-risk patients